Royce & Associates LP Purchases 55,545 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Royce & Associates LP increased its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 12.2% during the 3rd quarter, Holdings Channel reports. The firm owned 510,261 shares of the company’s stock after acquiring an additional 55,545 shares during the period. Royce & Associates LP’s holdings in Surgery Partners were worth $16,451,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Arizona State Retirement System raised its position in shares of Surgery Partners by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after purchasing an additional 359 shares during the period. KBC Group NV raised its position in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after purchasing an additional 576 shares during the period. Mackenzie Financial Corp raised its position in shares of Surgery Partners by 3.4% during the 2nd quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock valued at $476,000 after purchasing an additional 662 shares during the period. ProShare Advisors LLC raised its position in shares of Surgery Partners by 7.8% during the 1st quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares during the period. Finally, Natixis Advisors LLC grew its stake in Surgery Partners by 11.0% during the second quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after acquiring an additional 1,237 shares in the last quarter.

Analysts Set New Price Targets

Several research firms recently weighed in on SGRY. UBS Group began coverage on shares of Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company. Benchmark reaffirmed a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. Citigroup cut their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Finally, Macquarie cut their target price on shares of Surgery Partners from $35.00 to $34.00 and set an “outperform” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $40.71.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY opened at $22.95 on Friday. Surgery Partners, Inc. has a 52 week low of $22.25 and a 52 week high of $36.92. The stock has a market capitalization of $2.92 billion, a P/E ratio of -47.81, a PEG ratio of 18.74 and a beta of 2.76. The firm has a fifty day simple moving average of $30.62 and a two-hundred day simple moving average of $28.43. The company has a quick ratio of 1.69, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.